G protein mutations in endocrine diseases.

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• G protein signaling pathways are crucial in endocrine function.
• Naturally occurring mutations in G protein alpha subunits (Gsalpha and Gi2alpha) are implicated in endocrine disorders.
• While Gsalpha mutations are well-characterized, Gi2alpha's role is still under investigation.

Purpose of the Study:

• To review the pathogenetic role of G protein gene mutations in endocrine diseases.
• To explore the mechanisms and clinical manifestations of Gsalpha and Gi2alpha mutations.
• To consider potential roles of G protein beta/gamma subunits in disease.

Main Methods:

• Literature review of pathogenetic roles of G protein gene mutations.
• Analysis of in vitro mutagenesis and transfection assays.
• Examination of clinical data and genetic findings in endocrine diseases.

Main Results:

• Heterozygous inactivating GNAS1 mutations cause pseudohypoparathyroidism (PHP Ia) and pseudopseudohypoparathyroidism, associated with hormone resistance and Albright hereditary osteodystrophy (AHO).
• Activating somatic Gsalpha mutations are found in GH-secreting pituitary adenomas, thyroid adenomas, and Leydig cell tumors, and cause McCune-Albright syndrome when occurring early in embryogenesis.
• Activating Gi2alpha mutations are found in some ovarian, adrenal, and pituitary tumors, but their significance is debated.

Conclusions:

• Gsalpha mutations are key drivers of specific endocrine diseases, with GNAS1 imprinting potentially explaining tissue-specific effects.
• Activating Gsalpha mutations in tumors suggest a mitogenic role, though counteracting mechanisms may exist.
• Further research is needed to clarify the role of Gi2alpha mutations and G protein beta/gamma subunits in endocrine pathology.